StonvexLoading…
StonvexStonvexStonvexCore line items from EHTH's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $88.02M | $554.01M | $227.77M | $173.90M |
Operating Income | $-2.88M | $66.49M | $-59.77M | $-18.25M |
Net Income | $-4.71M | $40.04M | $-47.14M | $-17.40M |
EPS (Diluted) | $-0.58 | $-0.34 | $-2.78 | $-1.32 |
Total Assets | $1.20B | $1.26B | $1.05B | $1.08B |
Total Liabilities | $231.46M | $288.82M | $162.95M | $165.88M |
Cash & Equivalents | $75.11M | $73.72M | $63.09M | $65.92M |
Free Cash Flow OCF − CapEx | $35.61M | $-27.59M | $8.50M | $34.02M |
Shares Outstanding | 31.13M | 30.99M | 30.35M | 30.20M |